ArticleEuropean journal of medical research2025
Predictive value of seven scoring systems for 28-day mortality in ICU patients with Sleep apnea-hypopnea syndrome (SAHS) and clinical indicators.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predictive Value of SAPS II for 28-Day All-Cause Mortality in AECOPD Patients Admitted to the ICU.International journal of chronic obstructive pulmonary disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
BACKGROUND AND
objectiveSleep apnea-hypopnea syndrome (SAHS) is a chronic condition linked to recurrent upper airway collapse during sleep and has been associated with lower in-hospital mortality in ICU patients. This study evaluates the predictive efficacy of seven ICU scoring systems (Sequential Organ Failure Assessment (SOFA), Acute Physiology Score III (APSIII), Systemic Inflammatory Response Syndrome (SIRS), Simplified Acute Physiology Score II (SAPSII), Oxford Acute Severity of Illness Score (OASIS), Glasgow Coma Scale (GCS), and Charlson Comorbidity Index (CCI)) for 28-day all-cause mortality in SAHS patients.
methodsData from first-time ICU admissions were extracted from the MIMIC-IV database and analyzed using R, SPSS, and GraphPad Prism. Univariate and multivariate regression analyses identified independent risk factors for mortality. We evaluated the predictive accuracy of the scoring systems using calibration curves and the Hosmer-Lemeshow test. Decision curve analysis (DCA) and receiver operating characteristic (ROC) curves assessed the predictive performance of scoring systems.
resultsThe study showed that deceased patients had higher SOFA, APSIII, SIRS, SAPSII, OASIS, and CCI scores but lower GCS scores compared to survivors. SAPSII and APSIII demonstrated the highest net benefit and the area under the curve (AUC) values for predicting mortality, with APSIII showing the highest sensitivity and CCI the highest specificity. Kaplan-Meier analysis indicated lower mortality risk in low-risk subgroups of SAPSII and APSIII.
conclusionSAPSII score in this study demonstrated not only robust calibration but also showed high clinical net benefit and discriminative ability. APSIII demonstrated the highest sensitivity in predicting mortality outcomes. The CCI's specificity underscores the importance of addressing comorbidities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.